Current research projects
TELESCOPE – genetic screening study for those with geographical atrophy due to Dry AMD, recruiting till Nov 2021
There are 2 sites helping to recruit participants locally.
Vision and Hearing Support, Gateshead – contact Stephanie.email@example.com
Simon Berry Opticians – Simon@simonberry.co.uk
If you have potentially suitable patients who may like to participate please email either of the Optometrists above for further details. There will be referral fee for any patients recruited specifically for TELESCOPE.
- The study consists of 1 visit, where patients who provide their informed consent will be asked to provide a saliva sample that is shipped to a central laboratory for genotyping.
- If the patient meets the pre-specified genotype criteria, they may be able to enroll in an ongoing interventional gene therapy clinical trial.
- Inclusion Criteria
Subjects entered into the study must meet the following criteria:
Aged ≥55 years
Able and willing to give consent to study participation
Presence of unilateral or bilateral GA due to AMD
Subjects will not be eligible for the study if they meet any of the following criteria:
History or evidence of choroidal neovascularization (for example, wet AMD) in the either eye.
Presence of severe non-proliferative diabetic retinopathy or worse in either eye
Previous intravitreal injection in either eye for the treatment of nAMD.
Participation in another research study involving an investigational product received within 5 half-lives prior to the study visit or within 4 weeks until the expected pharmacodynamic effect has returned to baseline, whichever is longer
Received gene/cell therapy at any time previously.